Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OROS Methylphenidate in Adults with ADHD
NCT00937040Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Jul 2009
- Primary completion
- Feb 2010
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of methylphenidate osmotic release oral system in attention deficit hyperactivity disorder (ADHD), sponsored by Janssen Pharmaceutical. Started Jul 2009; status: completed.
02
Drugs
methylphenidate osmotic release oral system
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00937040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00937040.